Amanote Research
Register
Sign In
42. Synergistic Cancer Therapy by Simultaneous Expression and Silencing of Pro-Apoptotic and Pro-Survival Genes Using Chimeric Nanoparticles
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)34377-5
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2013
Authors
Unknown
Publisher
Elsevier BV
Related search
Deregulated Expression of Pro-Survival and Pro-Apoptotic P53-Dependent Genes Upon Elongator Deficiency in Colon Cancer Cells
Biochemical Pharmacology
Biochemistry
Pharmacology
Adaptation to ER Stress Is Mediated by Differential Stabilities of Pro-Survival and Pro-Apoptotic mRNAs and Proteins
PLoS Biology
Immunology
Molecular Biology
Genetics
Biochemistry
Microbiology
Biological Sciences
Agricultural
Neuroscience
Mapping the Interaction of Pro-Apoptotic tBID With Pro-Survival BCL-XL
Biochemistry
Biochemistry
The Development of Pro-Apoptotic Cancer Therapeutics
Mini-Reviews in Medicinal Chemistry
Medicine
Drug Discovery
Pharmacology
Double-Edged Lipid Nanoparticles Combining Liposome-Bound TRAIL and Encapsulated Doxorubicin Showing an Extraordinary Synergistic Pro-Apoptotic Potential
Cancers
Cancer Research
Oncology
Expression of Bbc3, a Pro-Apoptotic BH3-only Gene, Is Regulated by Diverse Cell Death and Survival Signals
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Involvement of Pro-Apoptotic and Pro-Autophagic Proteins in Granulosa Cell Death
Cell Biology
EGF Receptor and PKCδ Kinase Activate DNA Damage-Induced Pro-Survival and Pro-Apoptotic Signaling via Biphasic Activation of ERK and MSK1 Kinases
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Tumor-Penetrating Peptide Fused to a Pro-Apoptotic Peptide Facilitates Effective Gastric Cancer Therapy
Oncology Reports
Medicine
Cancer Research
Oncology
